US approval | Successful sale | Angling success
News covered here includes our assessment of pleasing results from a specialist fishing tackle retailer, although margins are slim and overseas expansion looks puzzling to us. Elsewhere in the retail world, trading remains tough for a seller of cosmetics, as it does for a specialist audio visual group. Read on here for our usual forthright views on this and other news.
Those interested in big dividend paying companies on AIM, of which there are a growing number, should take a look at our AIM for High Yield Portfolio here. Onto our thoughts on the latest news....Tristel: another product approval bodes well Tristel (AIM: TSTL), the manufacturer of infection prevention products, has received clearance from the US FDA for the immediate sale of Tristel OPH, it’s high-level disinfectant ("HLD") foam, for use on ophthalmic medical devices. With c.16 million ophthalmic procedures taking place every year in North America, FDA clearance has the potential to transform ophthalmic disinfection practice in the region. Until now,…